Your browser doesn't support javascript.
loading
Real-World Evaluation of Factors for Interstitial Lung Disease Incidence and Radiologic Characteristics in Patients With EGFR T790M-positive NSCLC Treated With Osimertinib in Japan.
Gemma, Akihiko; Kusumoto, Masahiko; Sakai, Fumikazu; Endo, Masahiro; Kato, Terufumi; Saito, Yoshinobu; Baba, Tomohisa; Sata, Masafumi; Yamaguchi, Ou; Yabuki, Yutaka; Nogi, Yuhiko; Jinushi, Masahisa; Sakamoto, Kei; Sugeno, Masatoshi; Tamura, Reiko; Tokimoto, Toshimitsu; Ohe, Yuichiro.
Afiliação
  • Gemma A; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Bunkyo-ku, Tokyo, Japan. Electronic address: agemma@nms.ac.jp.
  • Kusumoto M; Department of Diagnostic Radiology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Sakai F; Department of Diagnostic Radiology, Saitama Medical University International Medical Center, Hidaka-City, Saitama, Japan.
  • Endo M; Division of Diagnostic Radiology, Shizuoka Cancer Center, Sunto-gun, Shizuoka, Japan.
  • Kato T; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama-City, Kanagawa, Japan.
  • Saito Y; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Bunkyo-ku, Tokyo, Japan.
  • Baba T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama-City, Kanagawa, Japan.
  • Sata M; Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Shimotsuke-City, Tochigi, Japan.
  • Yamaguchi O; Department of Respiratory Medicine, Saitama Medical University International Medical Center, Hidaka-City, Saitama, Japan.
  • Yabuki Y; Medical Department, AstraZeneca K.K., Kita-ku, Osaka, Japan.
  • Nogi Y; Medical Department, AstraZeneca K.K., Kita-ku, Osaka, Japan.
  • Jinushi M; Medical Department, AstraZeneca K.K., Kita-ku, Osaka, Japan.
  • Sakamoto K; Research & Development, AstraZeneca K.K., Kita-ku, Osaka, Japan.
  • Sugeno M; Research & Development, AstraZeneca K.K., Kita-ku, Osaka, Japan.
  • Tamura R; Research & Development, AstraZeneca K.K., Kita-ku, Osaka, Japan.
  • Tokimoto T; Research & Development, AstraZeneca K.K., Kita-ku, Osaka, Japan.
  • Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
J Thorac Oncol ; 15(12): 1893-1906, 2020 12.
Article em En | MEDLINE | ID: mdl-32927121
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Neoplasias Pulmonares Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Neoplasias Pulmonares Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article